Orchestra BioMed
Price & Volume
Stats
See more52W Range | $2.20-$6.50 |
Market Cap | $132.7M |
Shares Short | 736,659 |
Financials
See moreRevenue (12 Mos) | $2.9M |
Revenue Growth (YoY) | 7.5% |
Gross Profit (12 Mos) | $2.7M |
Diluted EPS | -$1.86 |
News
See moreYahoo Finance • 27 days ago
Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout
Yahoo Finance • last month
Orchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology
Yahoo Finance • 2 months ago
AVIM therapy shows promise for patients with diastolic dysfunction
Yahoo Finance • 2 months ago
Orchestra BioMed GAAP EPS of -$0.50, revenue of $0.84M
About
CEO | Mr. David P. Hochman |
Address | 150 Union Square Drive, New Hope, PA, United States, 18938 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 70 |
